Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET

T Binderup, U Knigge, A Loft, J Mortensen… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Functional techniques are playing a pivotal role in the imaging of cancer today. Our aim was
to compare, on a head-to-head basis, 3 functional imaging techniques in patients with …

18F-AlF-NOTA-octreotide outperforms 68Ga-DOTATATE/NOC PET in neuroendocrine tumor patients: results from a prospective, multicenter study

E Pauwels, F Cleeren, T Tshibangu… - Journal of Nuclear …, 2023 - Soc Nuclear Med
18F-labeled somatostatin analogs (SSAs) could represent a valid alternative to the current
gold standard, 68Ga-labeled SSAs, for somatostatin receptor imaging in patients with …

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with 111In-Pentetreotide

DJ Kwekkeboom, EP Krenning, K Scheidhauer… - …, 2009 - karger.com
Dik J. Kwekkeboom a Eric P. Krenning a Klemens Scheidhauer b Val Lewington c Rachida
Lebtahi d Ashley Grossman e Pavel Vitek f Anders Sundin g Ursula Plöckinger h and the …

[HTML][HTML] Prognostic implications of PET-derived tumor volume and uptake in patients with neuroendocrine tumors

M Weber, T Telli, D Kersting, R Seifert - Cancers, 2023 - mdpi.com
Simple Summary The monitoring of disease in patients with neuroendocrine tumors is
challenging and requires specialized imaging techniques. To address these quests …

Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET

A Becherer, M Szabó, G Karanikas… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Nuclear medicine plays an important role in the imaging of neuroendocrine tumors (NETs).
Somatostatin receptor scintigraphy (SRS) with 111In-labeled somatostatin receptor analogs …

Somatostatin Receptor‐Based Molecular Imaging and Therapy for Neuroendocrine Tumors

L Wang, K Tang, Q Zhang, H Li, Z Wen… - BioMed research …, 2013 - Wiley Online Library
Neuroendocrine tumors (NETs) are tumors originated from neuroendocrine cells in the body.
The localization and the detection of the extent of NETs are important for diagnosis and …

Contemporary nuclear medicine imaging of neuroendocrine tumours

KK Wong, RT Waterfield, MC Marzola, AF Scarsbrook… - Clinical radiology, 2012 - Elsevier
Neuroendocrine tumours (NETs) are rare, heterogeneous, and often hormonally active
neoplasms. Nuclear medicine (NM) imaging using single photon-and positron-emitting …

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

MF Bozkurt, I Virgolini, S Balogova, M Beheshti… - European journal of …, 2017 - Springer
Abstract Purpose & Methods Neuroendocrine neoplasms are a heterogenous group of
tumours, for which nuclear medicine plays an important role in the diagnostic work-up as …

Theranostics of neuroendocrine tumors

ST Lee, HR Kulkarni, A Singh, RP Baum - Visceral medicine, 2017 - karger.com
Somatostatin receptor positron emission tomography/computed tomography using 68 Ga-
labeled somatostatin analogs is the mainstay for the evaluation of receptor status in …

Somatostatin receptor 2–targeting compounds

DAS Duijzentkunst, DJ Kwekkeboom… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The molecular imaging and treatment of neuroendocrine tumors (NETs) with radiolabeled
somatostatin analogs represent a milestone in the development of theranostic compounds …